Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
addressing, adenocarcinoma, affinity, aforementioned, analyst, analytical, ankylosing, Asymptomatic, attend, autoinjector, axillary, Baqsimi, bind, BTK, caption, Centrexion, cloth, Colorado, Commonwealth, communicated, communicating, communication, conciliation, conclusion, confer, constitutionality, contrary, County, Crohn, deceptive, degradation, deposit, dermatology, Dermira, DIAD, dialogue, Divisional, doctrine, dominantly, draft, easier, Eddingpharm, EGFR, EMA, exceed, expiry, fall, frequently, FWK, glycopyrronium, Hakim, harbor, hepatocellular, immovable, ImmuNext, implicit, incorrect, inherited, inquired, interchangeable, Internet, IP, junction, Kentucky, knowledge, Lastly, lebrikizumab, literal, literally, manipulation, Mason, matter, maximizer, media, modernized, NaN, obesity, Optum, pandemic, passage, passed, PGR, Pharmachem, post, prepaid, Prime, print, Qbrexza, radio, rearranged, reconciling, reexamine, rehearing, rent, resiliency, Reyvow, sample, Saskatchewan, Scientific, selpercatinib, somatostatin, specialist, specialty, strike, subpoena, Suzhou, sweating, telephonic, television, Tokyo, transfection, Trijardy, TSA, uncontrolled, unlimited, unsuccessful, Vermont, Vitrakvi, Weiler, Wellcare, wholly, withdrawal, withdrawing, writ
Removed:
Abemaciclib, abundant, additive, Adocia, agricultural, Agriculture, AH, Amyvid, angioplasty, anticoccidial, APP, appealing, apply, atherectomy, attempting, baricitinib, benchmark, BMS, bordetella, bulimia, bulk, Cadillac, canine, cattle, century, chewable, Clinton, closure, Coban, cognitive, combining, commenced, companion, comparability, Complementaria, conditional, conditionally, consume, consumption, Conterno, coronary, Daiichi, de, Denagard, depressed, deteriorating, deterioration, DICOM, disagree, discontinuing, Divisa, division, Duramune, economy, ehf, empagliflozin, Enrique, enteric, EU, Euronext, Evista, excise, exclusive, exclusively, expressing, extraordinary, farm, feed, feline, field, fiscal, flea, focused, Gemzar, German, happier, Harrington, healthier, heartworm, Hexal, humanity, hydrochloride, Idec, identifying, inclusion, intervention, intestinal, invasive, investigating, KGaA, language, leasing, limiting, linagliptin, live, livestock, Lyme, mania, Maxiban, metformin, mission, modification, Monteban, monthly, nervosa, neuritic, Olaratumab, Optaflexx, outbreak, ovarian, panic, parasite, Parenteral, participant, Paylean, planned, Portrazza, poultry, pretax, processing, promoting, prospectively, Prozac, radioactive, recognizing, reconsider, recurrent, regulate, representative, requesting, respiratory, retrospectively, revolving, Rumensin, Russia, salespeople, salt, Sankyo, sarcoma, selective, Sherman, SICAD, situation, soft, software, stent, strongly, sundry, swine, syndrome, tablet, thrombotic, tissue, translate, Trump, Tylan, ultra, undergoing, Union, unpatentable, user, vaccine, Venezuela, Venezuelan, veterinary, Vetmedica, vision
Filing tables
Filing exhibits
- 10-K Annual report
- 4.3 Description of Company's Common Stock
- 4.4 Description of the Company's 1.000% Eur Notes Due 2022, 1.625% Eur Notes Due 202
- 4.5 Description of the Company's 6.77% Notes Due 2036
- 4.6 Description of the Company's 7 1/8% Notes Due 2025
- 4.7 Description of the Company's 0.625% Eur Notes Due 2031 and 1.700% Eur Notes Due
- 10.2 Eli Lilly and Company Performance Award (for Executive Officers)
- 10.3 Eli Lilly and Company Shareholder Value Award (for Executive Officers)
- 10.4 Eli Lilly and Company Relative Value Award
- 10.5 Restricted Stock Unit Award to an Executive Officer
- 21 List of Subsidiaries and Affiliates
- 23 Consent of Independent Registered Public Accounting Firm
- 31.1 Rule 13A-14(A) Certification of David A. Ricks, Chairman, President, & CEO
- 31.2 Rule 13A-14(A) Certification of Joshua L. Smiley, Senior Vice President and CFO
- 32 Section 1350 Certification
- Download Excel data file
- View Excel data file
Related press release
Associated LLY transcripts
LLY similar filings
Filing view
External links